We are live on ! Find out more
RVMDW icon

Revolution Medicines Warrant

24 hedge funds and large institutions have $1.71M invested in Revolution Medicines Warrant in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,868% more capital inflows, than outflows

Capital inflows: $937K | Capital outflows: $31.6K

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

1.72% more ownership

Funds ownership: 2.83% → 4.56% (+1.7%)

4% less funds holding

Funds holding: 25 → 24 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
4
Calls
$12.3​M
Puts
–
Net Calls
+$12.3​M
Net Calls Change
-⁠$10​M

RVMDW Hedge Fund Activity: Q4 2024 in Review

24 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Warrant (RVMDW) for Q4 2024, worth a combined $1.71M — up 64% from $1.04M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RVMDW and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was LMR Partners, opening a new position worth an estimated $767K. The largest seller was Citadel Advisors, exiting entirely with an estimated $3.31K sold.

  • 24 institutional investors held Revolution Medicines Warrant (RVMDW) as of Q4 2024, down from 25 in Q3 2024.
  • Funds reported $1.71M of Revolution Medicines Warrant stock for Q4 2024, up 64% quarter-over-quarter.
  • 3 funds opened new Revolution Medicines Warrant positions in Q4 2024 and 4 closed out, a net change of -1 holder.
  • The largest Revolution Medicines Warrant buyer in Q4 2024 was LMR Partners, an estimated $767K added.
  • The largest Revolution Medicines Warrant seller in Q4 2024 was Citadel Advisors, an estimated $3.31K sold.

Based on aggregated 13F filings for Q4 2024.